{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:08:13Z","timestamp":1750666093673,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873472"],"award-info":[{"award-number":["81873472"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Key Projects in the National Science and Technology Pillar Program of the 13th Five-Year Plan Period","award":["2017YFC1308300"],"award-info":[{"award-number":["2017YFC1308300"]}]},{"name":"the Key Projects in the National Science and Technology Pillar Program of the 12th Five-Year Plan Period","award":["2011BAI11B08"],"award-info":[{"award-number":["2011BAI11B08"]}]},{"name":"CAMS Innovation Fund for Medical Science","award":["2020-I2M-1-002"],"award-info":[{"award-number":["2020-I2M-1-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiac power output (CPO) is a powerful predictor of adverse outcomes in heart failure (HF). However, the original formula of CPO included the difference between mean arterial pressure and right atrial pressure (RAP). The prognostic performance of RAP-corrected CPO (CPO<jats:sub>RAP<\/jats:sub>) remains unknown in heart failure with preserved ejection fraction (HFpEF). We studied 101 HF patients with a left ventricular ejection fraction\u2009&gt;\u200940% who had pulmonary hypertension due to left heart disease. CPO<jats:sub>RAP<\/jats:sub> was significantly more discriminating than CPO in predicting outcomes (Delong test, <jats:italic>P<\/jats:italic>\u2009=\u20090.004). Twenty-five (24.8%) patients presented with dis-concordantly high CPO<jats:sub>RAP<\/jats:sub> and low CPO when stratified by the identified CPO<jats:sub>RAP<\/jats:sub> threshold of 0.547 W and the accepted CPO threshold of 0.803 W. These patients had the lowest RAP, and their cumulative incidence was comparable with those with concordantly high CPO and CPO<jats:sub>RAP<\/jats:sub> (<jats:italic>P<\/jats:italic>\u2009=\u20090.313). CPO<jats:sub>RAP<\/jats:sub> might identify patients with right ventricular involvement, thereby providing better prognostic performance than CPO in HFpEF.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s12265-023-10429-y","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T16:04:56Z","timestamp":1693325096000},"page":"448-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improved Prognostic Performance of Right Atrial Pressure-Corrected Cardiac Power Output in Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction"],"prefix":"10.1007","volume":"17","author":[{"given":"Yihang","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengchao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyuan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5093-4325","authenticated-orcid":false,"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"issue":"2","key":"10429_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jacc.2004.03.060","volume":"44","author":"R Fincke","year":"2004","unstructured":"Fincke R, Hochman JS, Lowe AM, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol. 2004;44(2):340\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2004.03.060.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10429_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ejhf.268","volume":"17","author":"JL Grodin","year":"2015","unstructured":"Grodin JL, Mullens W, Dupont M, et al. Prognostic role of cardiac power index in ambulatory patients with advanced heart failure. Eur J Heart Fail. 2015;17(7):689\u201396. https:\/\/doi.org\/10.1002\/ejhf.268.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10429_CR3","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.amjcard.2017.06.028","volume":"120","author":"O Yildiz","year":"2017","unstructured":"Yildiz O, Aslan G, Demirozu ZT, Yenigun CD, Yazicioglu N. Evaluation of resting cardiac power output as a prognostic factor in patients with advanced heart failure. Am J Cardiol. 2017;120(6):973\u20139. https:\/\/doi.org\/10.1016\/j.amjcard.2017.06.028.","journal-title":"Am J Cardiol"},{"issue":"2","key":"10429_CR4","doi-asserted-by":"publisher","first-page":"e013495","DOI":"10.1161\/CIRCIMAGING.121.013495","volume":"15","author":"T Harada","year":"2022","unstructured":"Harada T, Yamaguchi M, Omote K, et al. Cardiac power output is independently and incrementally associated with adverse outcomes in heart failure with preserved ejection fraction. Circ Cardiovasc Imaging. 2022;15(2):e013495. https:\/\/doi.org\/10.1161\/CIRCIMAGING.121.013495.","journal-title":"Circ Cardiovasc Imaging."},{"issue":"8520","key":"10429_CR5","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/s0140-6736(86)92006-4","volume":"2","author":"LB Tan","year":"1986","unstructured":"Tan LB. Cardiac pumping capability and prognosis in heart failure. Lancet. 1986;2(8520):1360\u20133. https:\/\/doi.org\/10.1016\/s0140-6736(86)92006-4.","journal-title":"Lancet"},{"issue":"10","key":"10429_CR6","doi-asserted-by":"publisher","first-page":"e007393","DOI":"10.1161\/CIRCHEARTFAILURE.120.007393","volume":"13","author":"HS Lim","year":"2020","unstructured":"Lim HS. Cardiac power output revisited. Circ Heart Fail. 2020;13(10):e007393. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007393.","journal-title":"Circ Heart Fail."},{"issue":"6","key":"10429_CR7","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1002\/ehf2.14093","volume":"9","author":"L Baldetti","year":"2022","unstructured":"Baldetti L, Pagnesi M, Gallone G, et al. Prognostic value of right atrial pressure-corrected cardiac power index in cardiogenic shock. ESC Heart Fail. 2022;9(6):3920\u201330. https:\/\/doi.org\/10.1002\/ehf2.14093.","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10429_CR8","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.cardfail.2021.11.001","volume":"28","author":"MN Belkin","year":"2022","unstructured":"Belkin MN, Alenghat FJ, Besser SA, Pinney SP, Grinstein J. Improved prognostic performance of cardiac power output with right atrial pressure: a subanalysis of the ESCAPE trial. J Card Fail. 2022;28(5):866\u20139. https:\/\/doi.org\/10.1016\/j.cardfail.2021.11.001.","journal-title":"J Card Fail"},{"key":"10429_CR9","doi-asserted-by":"publisher","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension [published correction appears in Eur Heart J. 2023;44(15):1312. Eur Heart J. 2022;43(38):3618\u20133731. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237","DOI":"10.1093\/eurheartj\/ehac237"},{"issue":"8","key":"10429_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/eurheartj\/ehy809","volume":"40","author":"M Obokata","year":"2019","unstructured":"Obokata M, Reddy YNV, Melenovsky V, Pislaru S, Borlaug BA. Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction. Eur Heart J. 2019;40(8):689\u201397. https:\/\/doi.org\/10.1093\/eurheartj\/ehy809.","journal-title":"Eur Heart J"},{"issue":"30","key":"10429_CR11","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1093\/eurheartj\/ehy331","volume":"39","author":"TM Gorter","year":"2018","unstructured":"Gorter TM, Obokata M, Reddy YNV, Melenovsky V, Borlaug BA. Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease. Eur Heart J. 2018;39(30):2825\u201335. https:\/\/doi.org\/10.1093\/eurheartj\/ehy331.","journal-title":"Eur Heart J"},{"issue":"12","key":"10429_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","volume":"141","author":"SJ Shah","year":"2020","unstructured":"Shah SJ, Borlaug BA, Kitzman DW, et al. Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute Working Group Summary. Circulation. 2020;141(12):1001\u201326. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.041886.","journal-title":"Circulation"},{"issue":"6","key":"10429_CR13","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/j.chest.2021.08.039","volume":"160","author":"C Inampudi","year":"2021","unstructured":"Inampudi C, Silverman D, Simon MA, et al. Pulmonary hypertension in the context of heart failure with preserved ejection fraction. Chest. 2021;160(6):2232\u201346. https:\/\/doi.org\/10.1016\/j.chest.2021.08.039.","journal-title":"Chest"},{"issue":"38","key":"10429_CR14","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1093\/eurheartj\/ehx184","volume":"38","author":"BA Borlaug","year":"2017","unstructured":"Borlaug BA, Obokata M. Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease. Eur Heart J. 2017;38(38):2874\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehx184.","journal-title":"Eur Heart J"},{"issue":"8 Pt 1","key":"10429_CR15","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jcmg.2018.08.019","volume":"12","author":"BA Borlaug","year":"2019","unstructured":"Borlaug BA, Obokata M. The other atrium in heart failure. JACC Cardiovasc Imaging. 2019;12(8 Pt 1):1471\u20133. https:\/\/doi.org\/10.1016\/j.jcmg.2018.08.019.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8 Pt 1","key":"10429_CR16","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.jcmg.2018.08.020","volume":"12","author":"S Jain","year":"2019","unstructured":"Jain S, Kuriakose D, Edelstein I, et al. Right atrial phasic function in heart failure with preserved and reduced ejection graction. JACC Cardiovasc Imaging. 2019;12(8 Pt 1):1460\u201370. https:\/\/doi.org\/10.1016\/j.jcmg.2018.08.020.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10429_CR17","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/ehf2.13853","volume":"9","author":"R Nagata","year":"2022","unstructured":"Nagata R, Harada T, Omote K, et al. Right atrial pressure represents cumulative cardiac burden in heart failure with preserved ejection fraction. ESC Heart Fail. 2022;9(2):1454\u201362. https:\/\/doi.org\/10.1002\/ehf2.13853.","journal-title":"ESC Heart Fail"},{"issue":"48","key":"10429_CR18","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1093\/eurheartj\/ehu193","volume":"35","author":"V Melenovsky","year":"2014","unstructured":"Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J. 2014;35(48):3452\u201362. https:\/\/doi.org\/10.1093\/eurheartj\/ehu193.","journal-title":"Eur Heart J"},{"issue":"1","key":"10429_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ejhf.1029","volume":"20","author":"TM Gorter","year":"2018","unstructured":"Gorter TM, van Veldhuisen DJ, Bauersachs J, et al. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(1):16\u201337. https:\/\/doi.org\/10.1002\/ejhf.1029.","journal-title":"Eur J Heart Fail."},{"issue":"10","key":"10429_CR20","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.cardfail.2021.05.010","volume":"27","author":"MN Belkin","year":"2021","unstructured":"Belkin MN, Kalantari S, Kanelidis AJ, et al. Aortic pulsatility index: a novel hemodynamic variable for evaluation of decompensated heart failure. J Card Fail. 2021;27(10):1045\u201352. https:\/\/doi.org\/10.1016\/j.cardfail.2021.05.010.","journal-title":"J Card Fail"},{"issue":"3","key":"10429_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cardfail.2015.11.012","volume":"22","author":"LB Cooper","year":"2016","unstructured":"Cooper LB, Mentz RJ, Stevens SR, et al. Hemodynamic predictors of heart failure morbidity and mortality: fluid or flow? J Card Fail. 2016;22(3):182\u20139. https:\/\/doi.org\/10.1016\/j.cardfail.2015.11.012.","journal-title":"J Card Fail"},{"issue":"4","key":"10429_CR22","doi-asserted-by":"publisher","first-page":"e007840","DOI":"10.1161\/CIRCHEARTFAILURE.120.007840","volume":"14","author":"M Guazzi","year":"2021","unstructured":"Guazzi M, Naeije R. Right heart phenotype in heart failure with preserved ejection fraction. Circ Heart Fail. 2021;14(4):e007840. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007840.","journal-title":"Circ Heart Fail."}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-023-10429-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-023-10429-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-023-10429-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T19:23:47Z","timestamp":1714159427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-023-10429-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10429"],"URL":"https:\/\/doi.org\/10.1007\/s12265-023-10429-y","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"type":"print","value":"1937-5387"},{"type":"electronic","value":"1937-5395"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"19 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study. This study was approved by the Institutional Review Board of Fuwai Hospital (Approval No. 2018-1041).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}